Boston Scientific Corp. Announces Executive and Director Changes
Ticker: BSX · Form: 8-K · Filed: Oct 23, 2025 · CIK: 885725
| Field | Detail |
|---|---|
| Company | Boston Scientific CORP (BSX) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, director-election
Related Tickers: BSX
TL;DR
BSX leadership shakeup: new directors elected, exec comp adjusted.
AI Summary
Boston Scientific Corporation (BSX) announced on October 22, 2025, changes in its executive and director roles. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key executives. Specific names and financial details related to these changes are not provided in this excerpt.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes, such as director elections and executive appointments, which typically carry low risk.
Key Players & Entities
- BOSTON SCIENTIFIC CORP (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Marlborough, Massachusetts (location) — Business address
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates departures of certain officers and directors, but does not specify the exact roles in this excerpt.
Who are the newly elected directors?
The filing states that directors have been elected, but their names are not provided in this excerpt.
Are there any changes to executive compensation arrangements?
Yes, the filing mentions compensatory arrangements of certain officers have been adjusted.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is October 22, 2025.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number for Boston Scientific Corporation is 04-2695240.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2025-10-23 16:21:46
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share BSX New York Stock
Filing Documents
- bsx-20251022.htm (8-K) — 25KB
- 0000885725-25-000048.txt ( ) — 176KB
- bsx-20251022.xsd (EX-101.SCH) — 3KB
- bsx-20251022_def.xml (EX-101.DEF) — 15KB
- bsx-20251022_lab.xml (EX-101.LAB) — 27KB
- bsx-20251022_pre.xml (EX-101.PRE) — 16KB
- bsx-20251022_htm.xml (XML) — 4KB
02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the "Company") that he will not stand for re-election at the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting"). Mr. Sununu has served as a member of the Board of Directors (the "Board") of the Company since April 2009 and currently serves as a member of the Audit Committee and the chair of the Nominating and Governance Committee. Mr. Sununu will continue to serve as a director and in his committee roles until the 2026 Annual Meeting. Mr. Sununu's decision not to stand for re-election at the 2026 Annual Meeting is not the result of any disagreement with the Company. The Board and Nominating and Governance Committee regularly review the size and composition of the Board and will continue to evaluate whether adding directors to the Board following Mr. Sununu's departure is in the best interest of the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 23, 2025 BOSTON SCIENTIFIC CORPORATION By: /s/ Susan Thompson Susan Thompson Vice President, Chief Corporate Counsel and Assistant Secretary